Showing results (41-50 of 140) with videos related to
Sort By:
Pageof 14
Communications Biology|August 3, 2019
The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cellsVin Yee Chung, Tuan Zea Tan, Jieru Ye, et al.Cell Reports|August 16, 2018
RUNX Poly(ADP-Ribosyl)ation and BLM Interaction Facilitate the Fanconi Anemia Pathway of DNA RepairLavina Sierra Tay, Vaidehi Krishnan, Haresh Sankar, et al.Oncotarget|October 4, 2014
A central role for TRPS1 in the control of cell cycle and cancer developmentLele Wu, Yuzhi Wang, Yan Liu, et al.Genome Biology|May 31, 2022
3D genome organization in the epithelial-mesenchymal transition spectrumQing You Pang, Tuan Zea Tan, Vignesh Sundararajan, et al.Oncotarget|May 27, 2015
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapyBee Luan Khoo, Soo Chin Lee, Prashant Kumar, et al.Plos One|August 17, 2013
EMT-induced stemness and tumorigenicity are fueled by the EGFR/Ras pathwayDominic Chih-Cheng Voon, Huajing Wang, Jason Kin Wai Koo, et al.Molecular Cancer Therapeutics|October 29, 2014
Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic responseRachel E Rempel, Xiaolei Jiang, Paul Fullerton, et al.Molecular Oncology|December 15, 2018
The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinomaMing Tan, Mohammad Asad, Valerie Heong, et al.Journal of Hematology & Oncology|March 9, 2018
A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseJianbiao Zhou, Sabrina Hui-Min Toh, Zit-Liang Chan, et al.Oncotarget|June 11, 2015
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Ruby Yun-Ju Huang, Kuee Theng Kuay, Tuan Zea Tan, et al.Pageof 14